U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 215309

OPZELURA (RUXOLITINIB PHOSPHATE)
EQ 1.5% BASE
Marketing Status: Prescription
Active Ingredient: RUXOLITINIB PHOSPHATE
Proprietary Name: OPZELURA
Dosage Form; Route of Administration: CREAM; TOPICAL
Strength: EQ 1.5% BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N215309
Product Number: 001
Approval Date: Sep 21, 2021
Applicant Holder Full Name: INCYTE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top